UPDATE 1-Celgene's third-quarter results beat as Otezla sales soar [Reuters]
CELGENE (CELG)
Last celgene earnings: 10/31 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.celgene.com
Company Research
Source: Reuters
UPDATE 1-Celgene's third-quarter results beat as Otezla sales soar | Reuters 2 Min Read (Adds full-year forecast, details on Q3 drug sales, compares with estimates) Oct 25 (Reuters) - Celgene Corp on Thursday reported a better-than-expected third-quarter profit as sales of psoriasis drug Otezla and its flagship cancer medicine Revlimid surged, and the biotech company raised its full-year revenue forecast. Sales of Otezla rose 40.3 percent to $432 million in the third quarter, well above of the average analyst estimate of $383.31 million, according to Refinitiv data. Sales of Celgene’s blockbuster Revlimid, which treats the blood cancer multiple myeloma, rose nearly 18 percent to $2.45 billion, but slightly below analysts’ estimates of $2.47 billion. Celgene raised its 2018 forecast for revenue to $15.2 billion from $15 billion. Excluding one-time items, Celgene earned $2.29 per share in the quarter, above Wall Street expectations of $2.22 per share. The U.S. biotech company said net i
Show less
Read more
Impact Snapshot
Event Time:
CELG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELG alerts
High impacting CELGENE news events
Weekly update
A roundup of the hottest topics